These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34112238)

  • 21. Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC.
    Wang Z; Su M; Xiang B; Zhao K; Qin B
    Biochem Biophys Res Commun; 2019 May; 512(4):716-722. PubMed ID: 30922567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA hsa_circ_0072309 inhibits non-small cell lung cancer progression by sponging miR-580-3p.
    Pang W; Huang F; Zhang X; Ye M; Huang Y; Huang X; Pang J; Cai C; Wang Z
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32293004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
    Zhang D; Hua M; Zhang N
    Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
    Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
    Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.
    Zeng F; You S; Dai X
    Histol Histopathol; 2022 May; 37(5):483-492. PubMed ID: 35098525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of circPVT1 in T cell acute lymphoblastic leukemia promoted cell proliferation via miR-30e/DLL4 induced activating NOTCH signaling.
    Jia Y; Gu W
    Pathol Res Pract; 2021 Aug; 224():153536. PubMed ID: 34237615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA SMARCA5 suppressed non-small cell lung cancer progression by regulating miR-670-5p/RBM24 axis.
    Zhang D; Ma Y; Ma Z; Liu S; Sun L; Li J; Zhao F; Li Y; Zhang J; Li S; Jiang J
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1071-1080. PubMed ID: 33085761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis.
    Zheng F; Xu R
    Biomed Pharmacother; 2020 Apr; 124():109828. PubMed ID: 31986409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
    Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA PVT1 silencing prevents ischemia-reperfusion injury in rat by targeting microRNA-125b and microRNA-200a.
    Luo C; Ling GX; Lei BF; Feng X; Xie XY; Fang C; Li YG; Cai XW; Zheng BS
    J Mol Cell Cardiol; 2021 Oct; 159():80-90. PubMed ID: 34097926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA Plasmacytoma Variant Translocation 1 (CircPVT1) knockdown ameliorates hypoxia-induced bladder fibrosis by regulating the miR-203/Suppressor of Cytokine Signaling 3 (SOCS3) signaling axis.
    Li T; Xing Y; Zhang G; Wang Y; Wei Y; Cui L; Zhang S; Wang Q
    Bioengineered; 2022 Jan; 13(1):1288-1303. PubMed ID: 35000524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. circHIPK3 Acts as Competing Endogenous RNA and Promotes Non-Small-Cell Lung Cancer Progression through the miR-107/BDNF Signaling Pathway.
    Hong W; Zhang Y; Ding J; Yang Q; Xie H; Gao X
    Biomed Res Int; 2020; 2020():6075902. PubMed ID: 33015172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1.
    Cheng Z; Yu C; Cui S; Wang H; Jin H; Wang C; Li B; Qin M; Yang C; He J; Zuo Q; Wang S; Liu J; Ye W; Lv Y; Zhao F; Yao M; Jiang L; Qin W
    Nat Commun; 2019 Jul; 10(1):3200. PubMed ID: 31324812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circLDB2 functions as a competing endogenous RNA to suppress development and promote cisplatin sensitivity in non-squamous non-small cell lung cancer.
    Wang Y; Li L; Zhang W; Zhang G
    Thorac Cancer; 2021 Jul; 12(13):1959-1972. PubMed ID: 34096174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA expression profile of lung squamous cell carcinoma: identification of potential biomarkers and therapeutic targets.
    Wang Y; Zhang H; Wang J; Li B; Wang X
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4.
    Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F
    J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting
    Qi Y; Hou Y; Qi L
    J Environ Sci Health C Toxicol Carcinog; 2021; 39(3):251-268. PubMed ID: 34165043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.
    Mo Y; Wang Y; Wang Y; Deng X; Yan Q; Fan C; Zhang S; Zhang S; Gong Z; Shi L; Liao Q; Guo C; Li Y; Li G; Zeng Z; Jiang W; Xiong W; Xiang B
    Mol Cancer; 2022 Oct; 21(1):192. PubMed ID: 36199071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.